Illumina

Illumina, Inc.
legal form	Public
ISIN	US4523271090
founding	1998
Seat	San Diego , California ,
management	Francis deSouza ( CEO ); Jay T. Flatley (Executive Chairman);
Number of employees	6200
sales	2.75 billion US dollars
Branch	biotechnology
Website	www.illumina.com
	Status: Template: FormatDate : Invalid date!

Illumina is a US manufacturer of genetic engineering equipment based in San Diego . The company was founded in 1998 and went public in 2000. From 1999 to late 2016, Illumina was headed by Jay Flatley.

In 2007 Illumina took over Solexa .

Illumina has a 71% market share in automated sequencing . Like Sanger sequencing, the sequencers detect using sequencing-by-synthesis (SBS).

Sequencer MiSeq
S. device HiSeq 2500

Individual evidence

↑ Management Team ( Memento from October 6, 2016 in the Internet Archive )
↑ Jay T. Flatley ( Memento from October 26, 2016 in the Internet Archive )
↑ An Introduction to Illumina's Next Gen Sequencing ( Memento from April 17, 2016 in the Internet Archive ), May 24, 2010
^ Matthew Herper: Illumina CEO Jay Flatley Built The DNA Sequencing Market. Now he's stepping down . In: Forbes . March 7, 2016 ( forbes.com ).
^ History of Illumina Sequencing
↑ Anne Hachmann: Who sequenced how . In: News from chemistry . tape 63 , no. 1 , 2015, p. 42-43 , doi : 10.1002 / nadc.201590009 .

32.870901 -117.198866Coordinates: 32 ° 52 '15.2 " N , 117 ° 11' 55.9" W.

[1] Management Team ( Memento from October 6, 2016 in the Internet Archive )

[2] Jay T. Flatley ( Memento from October 26, 2016 in the Internet Archive )

[3] An Introduction to Illumina's Next Gen Sequencing ( Memento from April 17, 2016 in the Internet Archive ), May 24, 2010

[4] Matthew Herper: Illumina CEO Jay Flatley Built The DNA Sequencing Market. Now he's stepping down . In: Forbes . March 7, 2016 ( forbes.com ).

[5] History of Illumina Sequencing

[6] Anne Hachmann: Who sequenced how . In: News from chemistry . tape 63 , no. 1 , 2015, p. 42-43 , doi : 10.1002 / nadc.201590009 .